PharmaBoardroom

Lonza Goes Big with Swiss Investments in Biologics, ADCs &…

In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in Visp, Western Switzerland: a huge…

Lucas Chan – Scientific Founder & CSO, CellVec

Lucas Chan, Scientific Founder and CSO of CellVec, a Singapore-based CDMO that specializes in the development and manufacture of viral vectors for…

Haijun Dong – CEO, BioDuro-Sundia

Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of the largest Contract Research,…

Marc-Olivier Geinoz – CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…

Top 5 Global CDMOs

As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last few decades, while big pharma…

Vaccines: Manufacturing & Supply Chain Complexity

Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…

Jacques Marbehant – Senior Vice President, Head of Global…

Belgian champion UCB's global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufacturing and supply chain…

Reconsidering Cell & Gene Therapy Manufacturing

Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating an inflection point in the ability…

Alvotech’s Four Traits for Biosimilars Success

Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for future growth via a very different…

Michael Quirmbach – CEO & President, CordenPharma

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the…

Anil Okay – General Manager, Adalvo & Chief Commercial…

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach, and commercial strategy…

Marina Lugova – CFO & Member of the Board of…

Chief Financial Officer Marina Lugova introduces pharmaceutical company Synbias Pharma’s evolving European footprint, how the company has been able…

Tagged with Manufacturing